Key information

Recruitment dates:

20 June, 2016 to 31 December, 2019
(Trial recruitment open)

Treatment stage:

supportive care/late effects

Trial investigator:

Prof. Claire Foster

University Hospital Southampton NHS Foundation Trust

Study contact details:

HORIZONS Co-Ordinating Centre
(Macmillan Survivorship Research Group)
Faculty of Health Sciences
University of Southampton
SO17 1BJ

 023 8059 6885 (Mon-Fri 0900-1700)
 HORIZONS@soton.ac.uk
   

Trial website:

Acronym:

HORIZONS

Clinical trial locations

Location list

Address:
University of Southampton
SO17 1BJ

Introduction

A growing number of people are living for many years after cancer treatment but we don’t yet know all the ways to support them to ensure the best possible recovery. This study is interested in how a diagnosis of cancer and its treatment affects a person’s life over time.

 

About the trial

This study will follow a large group of patients over time who have had a diagnosis of cancer. Participants will be asked to complete questionnaires to find out how people’s health and wellbeing is after diagnosis and treatment. This information will help in the understanding of the impact that cancer diagnosis and treatment has on everyday life. Recruitment will take place prior to treatment from hospitals across the UK.

The study is organised by Macmillan in conjunction with University Hospital Southampton NHS Foundation Trust and runs from approximately 50 hospitals throughout the UK. 

To find the nearest hospital, please contact:

HORIZONS Co-Ordinating Centre
(Macmillan Survivorship Research Group)
Faculty of Health Sciences
University of Southampton
SO17 1BJ

023 8059 6885 (Mon-Fri 0900-1700)

HORIZONS@soton.ac.uk 

Who can take part?

This study is for patients that have a diagnosis of either breast cancer who are under 50 years old, gynaecological cancer or non-Hodgkin lymphoma. Recruitment will take place prior to treatment from hospitals across the UK.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.